BRICS and global health

Acharya, Shambhu; Barber, Sarah-Louise; López-Acuña, Daniel; Menabde, Natela; Migliorini, Luigi; Molina, Joaquín; Schwartländer, Bernhard; Zurn, Pascal

doi:10.2471/blt.14.140889

Cited by 33 publications

(30 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…For example, the so-called “BRIC” countries of Brazil, Russia, India and China represent approximately 40% of the world’s population, but data regarding cardiovascular risk assessment in these countries are limited. 38 Furthermore, the degree to which individual risk assessment is affected by local characteristics that are not easily evaluated or integrated into a risk prediction models is uncertain. These may include factors such as local environment, diet, climate, air pollution, built environment, cultural factors, availability of healthcare, and genetic background.…”

Section: Guidelines For the Treatment Of Blood Cholesterolmentioning

confidence: 99%

Recent Update to the US Cholesterol Treatment Guidelines

2016

View full text Add to dashboard Cite

The 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guideline advocated several changes from the previous Adult Treatment Panel III (ATP III) Guidelines. Assuming full implementation, the 2013 ACC/AHA Guideline would identify approximately 13 million Americans to be newly eligible for consideration of statin therapy. Three features of the 2013 ACC/AHA Guideline primarily responsible for these differences are the specific risk assessment tool endorsed, the risk threshold considered sufficient to warrant primary prevention statin therapy, and the decision to not include cholesterol treatment targets. There is no consensus among international guidelines regarding the optimal approach to these three components. The 2013 ACC/AHA Guideline recommends assessing absolute risk with the pooled cohort equations, which were developed to improve upon previous risk assessment models by including stroke as an outcome and by broadening racial and geographic diversity. Leading international guidelines each recommend a different equation for absolute risk assessment. The 2013 ACC/AHA Guideline advises consideration of statin therapy for an estimated 10-year risk of atherosclerotic vascular disease of ≥7.5%, which is lower than the thresholds recommended by other leading international guidelines. Lastly, the 2013 ACC/AHA Guideline does not endorse a treat-to-target strategy, but instead specifies the appropriate intensity of statin for each risk category. This approach is shared by the National Institute for Health and Care Excellence (NICE) Guidelines but differs from other international guidelines. In this review, we summarize the 2013 ACC/AHA Cholesterol Guideline recommendations and compare them with recommendations from ATP III and other leading international guidelines.

show abstract

Section: Guidelines For the Treatment Of Blood Cholesterolmentioning

confidence: 99%

Recent Update to the US Cholesterol Treatment Guidelines

2016

View full text Add to dashboard Cite

show abstract

“…(…) I also believe that the economic cost of these diseases may be such that it negates the so-called benefits of modernization and economic growth. (ACHARYA, 2014 countries (YU, 2008;BARTSCH, 2007). The BRICS preventive strategy, which makes BRICS be a post-hegemonic power, is to divert the current institutions and not to oppose to the powers already established.…”

Section: Levelmentioning

confidence: 99%

The BRICS, A Post-Hegemonic Model With Its Own Normativity: How do the BRICS reach to influence WTO law through the oriented use of WHO policies?

Thiel¹

2019

View full text Add to dashboard Cite

In response to Krasner's view, exclusively focused on geopolitical tensions and power games on the world stage, Keohane’s counter-multilateralism approach brings a solution: that of cooperation. The fact remains that the explanation delivered by international relations overlooks the fundamental role of law. Currently, the BRICS legal policy presents itself as a paradigmatic model, which shows how Krasner's and Keohane's theories complement one another, thanks to their targeted use of international law. This paper aims to demonstrate that the BRICS — in defining an innovative and independent legal policy influence normativity processes — are a post-hegemonic construction, with their own normativity, intended to fight against the organized hypocrisy of our international system. In view of the question of how the BRICS participate in the moralization of capitalism, I have considered the hypothesis of a BRICS hegemony, in the sense that the forms of cooperation promoted by the group are innovative and are not corresponding to any concept currently in force: the group uses WTO and WHO's health policies to curb world trade regulations. The main idea of this paper is to try to articulate the international relations theories with a legal analysis. In other words, my working assumption is that to be able to design its own normativity, the group diverts the WTO's political and legal mechanisms, via the WHO's health requirements, and is, therefore, rising as a new hegemonic formation.

show abstract

“…Lara Gautier and colleagues (2014) Lastly, as with their original grouping, what seems to be the underlying characteristic of BRICS collaborations is economics. After all, despite inequalities, neoliberal economic reforms in BRICS are cited as having lifted hundreds of millions out of poverty, resulting in marked improvements in health (Acharya et al 2014). In 1990, BRICS countries had a GDP per capita below US$4,000, which increased to over US$6,000 by 2013 in each country except India (figure 2).…”

Section: Understanding Brics Health Collaborationsmentioning

confidence: 99%

BRICS health and tuberculosis control collaborations during an era of global health

Dirlikov¹

2015

MAT

View full text Add to dashboard Cite

In this think piece, I examine the difference introduced by BRICS (Brazil, Russia, India, China, and South Africa) health collaborations in an era of global health. Using tuberculosis control as a grounding example, I show that BRICS collaborations prioritize: state-led solutions, particularly through policies aimed at expanding universal health coverage; scientific and programmatic innovation; experience and technology sharing; clear benchmarks for progress, based on current best practices of control; and flexibility. Unlike international health, BRICS health collaborations are not primarily concerned with preventing the importation of infectious disease across national borders. Nor are they based on global health's concerns about global biosecurity or humanitarian biomedicine. Rather, BRICS collaborative health efforts fall within the nation-state paradigm, while also aspiring towards the global. They remain flexible in their operation, gesturing towards a neoliberal ethic. This flexibility allows BRICS to work within existing structures, while also establishing their own institutions from which to change traditional assistance relationships.

show abstract

BRICS and global health

Cited by 33 publications

References 13 publications

Recent Update to the US Cholesterol Treatment Guidelines

Recent Update to the US Cholesterol Treatment Guidelines

The BRICS, A Post-Hegemonic Model With Its Own Normativity: How do the BRICS reach to influence WTO law through the oriented use of WHO policies?

BRICS health and tuberculosis control collaborations during an era of global health

Contact Info

Product

Resources

About